Kurt Fernstrom
Examiner (ID: 5518, Phone: (571)272-4422 , Office: P/3711 )
Most Active Art Unit | 3711 |
Art Unit(s) | 3714, 3712, 3715, 3711 |
Total Applications | 2669 |
Issued Applications | 1756 |
Pending Applications | 157 |
Abandoned Applications | 755 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16969285
[patent_doc_number] => 11065231
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Compounds and methods for the targeted degradation of interleukin-1 receptor- associated kinase 4 polypeptides
[patent_app_type] => utility
[patent_app_number] => 16/194094
[patent_app_country] => US
[patent_app_date] => 2018-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 99906
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 694
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16194094
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/194094 | Compounds and methods for the targeted degradation of interleukin-1 receptor- associated kinase 4 polypeptides | Nov 15, 2018 | Issued |
Array
(
[id] => 16336542
[patent_doc_number] => 10787486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-29
[patent_title] => Template-fixed peptidomimetics
[patent_app_type] => utility
[patent_app_number] => 16/190459
[patent_app_country] => US
[patent_app_date] => 2018-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 6295
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16190459
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/190459 | Template-fixed peptidomimetics | Nov 13, 2018 | Issued |
Array
(
[id] => 16539391
[patent_doc_number] => 20200405804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => COMPOSITIONS AND METHOD FOR THE TREATMENT OF X-LINKED CENTRONUCLEAR MYOPATHY
[patent_app_type] => utility
[patent_app_number] => 16/762953
[patent_app_country] => US
[patent_app_date] => 2018-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762953
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/762953 | Compositions and method for the treatment of x-linked centronuclear myopathy | Nov 11, 2018 | Issued |
Array
(
[id] => 14040789
[patent_doc_number] => 20190076501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => OXYTOCIN IMPROVES TREATMENT OF OBSTRUCTIVE SLEEP APNEA
[patent_app_type] => utility
[patent_app_number] => 16/184091
[patent_app_country] => US
[patent_app_date] => 2018-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16184091
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/184091 | Oxytocin improves treatment of obstructive sleep apnea | Nov 7, 2018 | Issued |
Array
(
[id] => 17664195
[patent_doc_number] => 11357871
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => Challenge test for diagnosing subtypes of ASD
[patent_app_type] => utility
[patent_app_number] => 16/182544
[patent_app_country] => US
[patent_app_date] => 2018-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9367
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16182544
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/182544 | Challenge test for diagnosing subtypes of ASD | Nov 5, 2018 | Issued |
Array
(
[id] => 16908100
[patent_doc_number] => 11040117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-22
[patent_title] => Treatment of a subtype of ASD
[patent_app_type] => utility
[patent_app_number] => 16/182546
[patent_app_country] => US
[patent_app_date] => 2018-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6832
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16182546
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/182546 | Treatment of a subtype of ASD | Nov 5, 2018 | Issued |
Array
(
[id] => 17680080
[patent_doc_number] => 11364311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Method of identifying ASD phenotype 1 patients
[patent_app_type] => utility
[patent_app_number] => 16/182539
[patent_app_country] => US
[patent_app_date] => 2018-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9022
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16182539
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/182539 | Method of identifying ASD phenotype 1 patients | Nov 5, 2018 | Issued |
Array
(
[id] => 15466181
[patent_doc_number] => 10548944
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-02-04
[patent_title] => Antimicrobial peptides and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 16/165727
[patent_app_country] => US
[patent_app_date] => 2018-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 20760
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16165727
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/165727 | Antimicrobial peptides and methods of using the same | Oct 18, 2018 | Issued |
Array
(
[id] => 16948123
[patent_doc_number] => 20210206814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => METHODS AND MATERIALS FOR GENE EDITING
[patent_app_type] => utility
[patent_app_number] => 16/754898
[patent_app_country] => US
[patent_app_date] => 2018-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754898
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/754898 | METHODS AND MATERIALS FOR GENE EDITING | Oct 11, 2018 | Abandoned |
Array
(
[id] => 16310878
[patent_doc_number] => 20200289616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => HUMAN CANCER CELL METASTASIS INHIBITORY AGENT AND HUMAN CANCER CELL DETERMINATION AGENT
[patent_app_type] => utility
[patent_app_number] => 16/765757
[patent_app_country] => US
[patent_app_date] => 2018-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10208
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16765757
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/765757 | Human cancer cell metastasis inhibitory agent and human cancer cell determination agent | Sep 25, 2018 | Issued |
Array
(
[id] => 18620421
[patent_doc_number] => 11753449
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Immunoglobulin binding protein, and affinity support using same
[patent_app_type] => utility
[patent_app_number] => 16/649879
[patent_app_country] => US
[patent_app_date] => 2018-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14325
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16649879
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/649879 | Immunoglobulin binding protein, and affinity support using same | Sep 24, 2018 | Issued |
Array
(
[id] => 14132329
[patent_doc_number] => 20190100554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => METHOD FOR SYNTHESIZING ETELCALCETIDE OR SALTS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/137967
[patent_app_country] => US
[patent_app_date] => 2018-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16137967
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/137967 | Method for synthesizing etelcalcetide or salts thereof | Sep 20, 2018 | Issued |
Array
(
[id] => 16437081
[patent_doc_number] => 20200354407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => PEPTIDE INHIBITORS OF INSULIN-DEGRADING ENZYME
[patent_app_type] => utility
[patent_app_number] => 16/641995
[patent_app_country] => US
[patent_app_date] => 2018-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16641995
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/641995 | Peptide inhibitors of insulin-degrading enzyme | Sep 10, 2018 | Issued |
Array
(
[id] => 16776630
[patent_doc_number] => 20210113707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => AMANITIN ANTIBODY CONJUGATE
[patent_app_type] => utility
[patent_app_number] => 16/970597
[patent_app_country] => US
[patent_app_date] => 2018-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6223
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970597
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/970597 | AMANITIN ANTIBODY CONJUGATE | Sep 7, 2018 | Abandoned |
Array
(
[id] => 17281691
[patent_doc_number] => 11198711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => Pesticidal fusion protein improvements
[patent_app_type] => utility
[patent_app_number] => 16/123860
[patent_app_country] => US
[patent_app_date] => 2018-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 15971
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16123860
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/123860 | Pesticidal fusion protein improvements | Sep 5, 2018 | Issued |
Array
(
[id] => 18201217
[patent_doc_number] => 11583589
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Cell membrane penetrating conjugates
[patent_app_type] => utility
[patent_app_number] => 16/640865
[patent_app_country] => US
[patent_app_date] => 2018-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 30
[patent_no_of_words] => 21624
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16640865
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/640865 | Cell membrane penetrating conjugates | Aug 21, 2018 | Issued |
Array
(
[id] => 17952454
[patent_doc_number] => 11478528
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Antimicrobial peptides against
[patent_app_type] => utility
[patent_app_number] => 16/630615
[patent_app_country] => US
[patent_app_date] => 2018-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 22
[patent_no_of_words] => 14925
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630615
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/630615 | Antimicrobial peptides against | Jul 15, 2018 | Issued |
Array
(
[id] => 16799102
[patent_doc_number] => 10994018
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-04
[patent_title] => Long-acting palmitic acid-conjugated GnRH derivative, and pharmaceutical composition containing same
[patent_app_type] => utility
[patent_app_number] => 16/630704
[patent_app_country] => US
[patent_app_date] => 2018-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5395
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630704
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/630704 | Long-acting palmitic acid-conjugated GnRH derivative, and pharmaceutical composition containing same | Jun 19, 2018 | Issued |
Array
(
[id] => 18664874
[patent_doc_number] => 11771739
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Methods and compositions for treating microbial inflammation
[patent_app_type] => utility
[patent_app_number] => 16/622469
[patent_app_country] => US
[patent_app_date] => 2018-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19377
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622469
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622469 | Methods and compositions for treating microbial inflammation | Jun 17, 2018 | Issued |
Array
(
[id] => 13604755
[patent_doc_number] => 20180353926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => Preparation of Templates for Nucleic Acid Sequencing
[patent_app_type] => utility
[patent_app_number] => 16/010902
[patent_app_country] => US
[patent_app_date] => 2018-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16010902
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/010902 | Preparation of templates for nucleic acid sequencing | Jun 17, 2018 | Issued |